• Clozapine N-oxide (CNO): Chemogenetic Actuator for Precis...

  2025-11-30

  Clozapine N-oxide (CNO) is a biologically inert metabolite of clozapine and a gold-standard chemogenetic actuator for DREADDs in neuroscience research. As supplied by APExBIO, CNO enables precise, reversible modulation of neuronal circuits and GPCR signaling with minimal off-target activity.

• Cisapride (R 51619): Unlocking Predictive Cardiotoxicity ...

  2025-11-29

  Explore the multifaceted role of Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and hERG potassium channel inhibitor, in predictive cardiotoxicity and translational research. Discover unique insights into advanced screening strategies, mechanistic applications, and next-generation models that set this analysis apart.

• Clozapine N-oxide (CNO): Reliable Chemogenetic Actuation ...

  2025-11-28

  Discover how Clozapine N-oxide (CNO, SKU A3317) overcomes recurring laboratory challenges in cell viability and neuronal modulation assays. This scenario-driven guide equips biomedical researchers and lab technicians with evidence-based strategies for reproducible, sensitive, and safe chemogenetic workflows using CNO. Leverage data-backed insights to optimize experimental design, data interpretation, and vendor selection.

• Cisapride (R 51619): Nonselective 5-HT4 Agonist and hERG ...

  2025-11-27

  Cisapride (R 51619) is a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor used in cardiac electrophysiology and predictive cardiotoxicity research. High purity, robust solubility in DMSO, and proven utility in iPSC-cardiomyocyte assays make it a reference compound for 5-HT4 signaling and arrhythmia studies.

• Perospirone (SM-9018 Free Base): Atomic Mechanisms in Sch...

  2025-11-26

  Perospirone (SM-9018 free base) is a potent atypical antipsychotic agent for schizophrenia research, acting as a 5-HT2A and D2 antagonist and partial 5-HT1A agonist. Recent studies add Kv1.5 channel inhibition to its mechanistic profile, expanding its utility for neuropsychiatric and cardiovascular disorder models.

• Clozapine N-oxide (CNO): Scenario-Driven Solutions for Re...

  2025-11-25

  This authoritative article delivers evidence-backed, scenario-driven guidance for biomedical researchers and lab technicians using Clozapine N-oxide (CNO, SKU A3317). By addressing real-world assay challenges in cell viability, proliferation, and chemogenetic modulation, it demonstrates how CNO’s inertness and selectivity as a DREADDs activator support reproducible, interpretable data. Practical comparisons, protocol optimization, and vendor reliability are anchored by the latest literature and product-specific insights.

• Cisapride (R 51619): Optimizing Cardiac Electrophysiology...

  2025-11-24

  This article provides an evidence-based, scenario-driven guide to deploying Cisapride (R 51619) (SKU B1198) in cutting-edge cell viability and cardiac electrophysiology assays. By addressing real laboratory challenges—ranging from assay compatibility to reliable vendor selection—we illustrate how Cisapride (R 51619) delivers data-backed solutions for reproducible, high-throughput research. Explore best practices for maximizing assay sensitivity and experimental confidence using this high-purity compound.

• Precision Chemogenetics: Clozapine N-oxide (CNO) as a Str...

  2025-11-23

  Explore how Clozapine N-oxide (CNO), a metabolite of clozapine and a selective chemogenetic actuator, is reshaping translational neuroscience. This thought-leadership article bridges mechanistic insight with strategic guidance, contextualizing CNO’s role in DREADDs-based neuronal modulation, recent scientific breakthroughs—including its use in chronic migraine models—and the future of GPCR signaling research. Discover how APExBIO’s CNO (SKU A3317) empowers researchers to push beyond traditional paradigms for more reproducible, targeted, and clinically-relevant outcomes.

• Perospirone (SM-9018 Free Base): Advanced Insights into R...

  2025-11-22

  Explore Perospirone (SM-9018 free base), an atypical antipsychotic agent for schizophrenia, through a deep dive into its dual receptor and ion channel mechanisms. Uncover novel implications for neuropsychiatric and cardiovascular disorder models, uniquely synthesized from recent research breakthroughs.

• Clozapine N-oxide: Precision Chemogenetic Actuator for Ne...

  2025-11-21

  Clozapine N-oxide (CNO) enables non-invasive, reversible neuronal modulation, empowering researchers to dissect complex brain circuits with unprecedented specificity. As a DREADDs activator and metabolite of clozapine, CNO stands out for its biological inertness and reliability in GPCR signaling research and anxiety studies. Discover stepwise protocols, troubleshooting insights, and advanced use-cases that maximize the impact of this essential neuroscience research tool.

• Cisapride (R 51619): Benchmarking Cardiac Electrophysiolo...

  2025-11-20

  Cisapride (R 51619) stands at the forefront of cardiac electrophysiology and gastrointestinal motility research, serving as a robust tool for dissecting 5-HT4 receptor signaling and hERG channel inhibition. Its high purity, compatibility with iPSC-derived models, and validated use in deep learning-enabled phenotypic screens make it indispensable for predictive drug safety and translational workflows.

• Perospirone (SM-9018 Free Base): Expanding the Frontiers ...

  2025-11-19

  Discover how Perospirone (SM-9018 free base), an atypical antipsychotic agent for schizophrenia, uniquely bridges serotonergic-dopaminergic signaling and vascular ion channel modulation. This article explores advanced research applications and emerging cardiovascular considerations, offering profound insight beyond conventional neuropsychiatric models.

• Cisapride (R 51619): Nonselective 5-HT4 Agonist & hERG Ch...

  2025-11-18

  Cisapride (R 51619) is a high-purity, nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor used in cardiac electrophysiology research. Its robust solubility profile and validated performance in iPSC-derived cardiomyocyte assays make it a benchmark compound for modeling drug-induced cardiotoxicity. APExBIO provides Cisapride B1198 with rigorous QC documentation for reproducible research.

• Clozapine N-oxide (CNO): Advanced Chemogenetic Tools for ...

  2025-11-17

  Explore the pivotal role of Clozapine N-oxide (CNO) as a chemogenetic actuator in neuroscience research. This article offers a unique, in-depth analysis of CNO’s mechanistic action, its distinct advantages for circuit-specific modulation, and insights from recent research on light-induced anxiety, distinguishing it from standard reviews.

• Perospirone (SM-9018 Free Base): Charting a New Mechanist...

  2025-11-16

  This thought-leadership article dissects the multidimensional pharmacology of Perospirone (SM-9018 free base)—an atypical antipsychotic agent for schizophrenia—and offers translational researchers actionable strategies to leverage its unique receptor and ion channel mechanisms. Integrating recent evidence of Kv1.5 inhibition, we showcase how Perospirone enables advanced modeling of neuropsychiatric and vascular comorbidities, outpacing conventional antipsychotic research paradigms.

15438 records 1/1030 page Next 12345 下5页 Last page